Close Menu

NEW YORK (GenomeWeb) – Rainbow Genomics said today that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment tests in Hong Kong.

Rainbow, a preferred partner of Color in Hong Kong, will offer that firm's genetic tests for the analysis of a patient's risk for eight hereditary cancers and four hereditary heart health conditions. The partnership, Rainbow said, will provide a fully integrated solution for actionable clinical test results at an affordable price point, though it did not elaborate.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.